{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:32:04Z","timestamp":1786375924844,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10928-026-10041-y","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:51:13Z","timestamp":1780599073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL"],"prefix":"10.1007","volume":"53","author":[{"given":"Mahdi","family":"Rabbani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ehsan","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Goharimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ehsan","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"8","key":"10041_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102264","volume":"7","author":"D Coffin","year":"2023","unstructured":"Coffin D et al (2023) The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients. Res Pract Thromb Haemost 7(8):102264","journal-title":"Res Pract Thromb Haemost"},{"key":"10041_CR2","doi-asserted-by":"crossref","unstructured":"Chernyi N et al (2024) Recent advances in gene therapy for hemophilia: projecting the perspectives. Biomolecules 14.7 : 854","DOI":"10.3390\/biom14070854"},{"issue":"6","key":"10041_CR3","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.3390\/cimb46060309","volume":"46","author":"N Evangelidis","year":"2024","unstructured":"Evangelidis N et al (2024) Genetics and epigenetics in acquired hemophilia A: from bench to bedside. Curr Issues Mol Biol 46(6):5147\u20135160","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"10041_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12783","volume":"6","author":"M Chaigneau","year":"2022","unstructured":"Chaigneau M et al (2022) Challenges and knowledge gaps facing hemophilia carriers today: perspectives from patients and health care providers. Res Pract Thromb Haemost 6(6):e12783","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10041_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02413-7","volume":"17","author":"MN Islam","year":"2022","unstructured":"Islam MN et al (2022) Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh. Orphanet J Rare Dis 17(1):254","journal-title":"Orphanet J Rare Dis"},{"key":"10041_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01203-9","author":"X Lin","year":"2023","unstructured":"Lin X, Gao P, Zhang Q, Jiang Y, Wang O, Xia W, Li M. Pathogenesis and treatment of osteoporosis in patients with hemophilia. Arch Osteoporos. 2023 Jan 4;18(1):17. 10.1007\/s11657-022-01203-9. PMID: 36598583; PMCID: PMC9813251. https:\/\/doi.org\/10.1007\/s11657-022-01203-9","journal-title":"Arch Osteoporos"},{"key":"10041_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1618464","author":"Z Dushimova","year":"2025","unstructured":"Dushimova Z, Pashimov M, Kaibullayeva J, Danyarova L, Kultanova E, Abdilova G, Mustapayeva N. Therapeutic advances in hemophilia: from molecular innovation to patient-centered global care. Front Med (Lausanne). 2025 Sep 25;12:1618464. doi: 10.3389\/fmed.2025.1618464. PMID: 41080961; PMCID: PMC12507939. https:\/\/doi.org\/10.3389\/fmed.2025.1618464","journal-title":"Front Med (Lausanne)"},{"key":"10041_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2026.04.005","author":"A Srivastava","year":"2026","unstructured":"Lim, Ming Y., et al. \"Diagnosis and management of hemophilia A and B.\" Journal of Thrombosis and Haemostasis (2026). https:\/\/doi.org\/10.1016\/j.jtha.2026.04.005","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10041_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720966888","volume":"11","author":"C Hermans","year":"2020","unstructured":"Hermans C, Dolan G (2020) Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities\u2014a practical review. Ther Adv Hematol 11:2040620720966888","journal-title":"Ther Adv Hematol"},{"key":"10041_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115421","volume":"215","author":"IK Minichmayr","year":"2024","unstructured":"Minichmayr IK et al (2024) Model-informed precision dosing: state of the art and future perspectives. Adv Drug Deliv Rev 215:115421","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10041_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/hae.13935","volume":"26","author":"X Delavenne","year":"2020","unstructured":"Delavenne X et al (2020) A new paradigm for personalized prophylaxis for patients with severe haemophilia A. Haemophilia 26(2):228\u2013235","journal-title":"Haemophilia"},{"key":"10041_CR12","doi-asserted-by":"crossref","unstructured":"Depasse F et al (2021) Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine. J Thromb Haemost 19(12):2907\u20132917 (in eng)","DOI":"10.1111\/jth.15529"},{"key":"10041_CR13","doi-asserted-by":"crossref","unstructured":"Binder NB et al (2021) Clinical use of thrombin generation assays, (in eng), J Thromb Haemost, 19(12):2918\u20132929","DOI":"10.1111\/jth.15538"},{"issue":"3","key":"10041_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","volume":"21","author":"JR Shaw","year":"2023","unstructured":"Shaw JR et al (2023) DOAC\u2013associated bleeding, hemostatic strategies, and thrombin generation assays-a review of the literature. J Thromb Haemost 21(3):433\u2013452","journal-title":"J Thromb Haemost"},{"key":"10041_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1033416","volume":"9","author":"LL Valke","year":"2022","unstructured":"Valke LL et al (2022) Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases. Front Cardiovasc Med 9:1033416","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10041_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ijlh.14406","volume":"47","author":"L Josset","year":"2025","unstructured":"Josset L, Rezigue H, Dargaud Y (2025) Thrombin generation assay to support hematologists in the era of new hemophilia therapies. Int J Lab Hematol 47(2):212\u2013220","journal-title":"Int J Lab Hematol"},{"key":"10041_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719860025","volume":"10","author":"H Kizilocak","year":"2019","unstructured":"Kizilocak H et al (2019) Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on Emicizumab using global hemostasis assays. Ther Adv Hematol 10:2040620719860025","journal-title":"Ther Adv Hematol"},{"issue":"8","key":"10041_CR18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.215129","volume":"104","author":"E Santagostino","year":"2019","unstructured":"Santagostino E et al (2019) Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on Emicizumab prophylaxis undergoing hip replacement. Haematologica 104(8):e380","journal-title":"Haematologica"},{"issue":"12","key":"10041_CR19","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/jth.15529","volume":"19","author":"F Depasse","year":"2021","unstructured":"Depasse F et al (2021) Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine. J Thromb Haemost 19(12):2907\u20132917","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10041_CR20","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.rpth.2022.100018","volume":"7","author":"F Sidonio Jr","year":"2023","unstructured":"Sidonio F Jr et al (2023) Thrombin generation and implications for hemophilia therapies: A narrative review. Res Pract Thromb Haemostasis 7(1):100018","journal-title":"Res Pract Thromb Haemostasis"},{"key":"10041_CR21","doi-asserted-by":"crossref","unstructured":"Janssen A et al (2025) A repeated time-to-event model for personalised treatment of patients with haemophilia A based on individual bleeding risk. J Thromb Haemost","DOI":"10.1016\/j.jtha.2025.05.023"},{"issue":"12","key":"10041_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/psp4.12464","volume":"8","author":"JA Abrantes","year":"2019","unstructured":"Abrantes JA et al (2019) Bayesian forecasting utilizing bleeding information to support dose individualization of factor VIII. CPT Pharmacomet Syst Pharmacol 8(12):894\u2013903","journal-title":"CPT Pharmacomet Syst Pharmacol"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10041-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10041-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10041-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:25:51Z","timestamp":1786375551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10041-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10041"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10041-y","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28"}}